Harrison, NY24 Active Studies

Ankylosing Spondylitis Clinical Trials in Harrison, NY

Find 24 actively recruiting ankylosing spondylitis clinical trials in Harrison, NY. Connect with local research sites and explore new treatment options.

24
Active Trials
2
Sponsors
2,252
Enrolling

Recruiting Ankylosing Spondylitis Studies in Harrison

RecruitingHarrison, NYNCT06144164

A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer....

285 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT04084730

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a safe approach that cause...

280 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05789485

A Study on the Effects of Exercise on Side Effects From Treatment for Gastrointestinal Cancers

The purpose of this study is to find the level of aerobic exercise (AT) that is practical, is safe, and has positive effects on the body that may reduce the side effects of therapy. The study will als...

216 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06099769

A Study of Enzalutamide, Enzalutamide in Combination With Mifepristone, or Chemotherapy in People With Metastatic Breast Cancer

The researchers are doing this study to find out if the study drug, enzalutamide, alone or combined with the study drug, mifepristone, is effective in treating advanced or metastatic androgen receptor...

201 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT03351348

Bupivacaine vs Placebo for Unilateral Mastectomy Surgical Site Post-operative Pain Control

The purpose of this study is to compare using FDA-approved bupivacaine (a numbing medicine), along with the usual medications for post-operative pain control to using the usual medications for postope...

165 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT07053085

A Study of Surgery and Radiotherapy in People With Breast Cancer

The researchers are doing this study to see if the combination of surgery, locoregional radiation therapy, SBRT (stereotactic body radiation therapy), and the usual approach is more effective in treat...

162 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT03808337

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

This study is being done to determine if stereotactic body radiotherapy (SBRT) when delivered to all sites of disease in participants with 1-5 metastases will increase the length of time before partic...

145 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05716893

Study of Aerobic Training for People Receiving Chemotherapy for Breast Cancer

In this study, investigators will compare standard Aerobic Training/AT with adaptive Aerobic Training/AT. Standard AT will be a fixed (unchanging) amount of walking each week, while adaptive AT will a...

140 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06057948

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

The purpose of this study is to test which treatment schedule of β-glucan with bivalent vaccine is more effective for participants with high-risk neuroblastoma that is in complete remission....

94 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT07042581

A Study of Revaree Plus in People With Breast Cancer

The purpose of this study is to find out whether Revaree Plus is effective at improving vaginal health for people who are having symptoms of vaginal dryness during breast cancer treatment....

60 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05570253

A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

The researchers are doing this study to find out whether the study drug, SDX-7320, when combined with the standard chemotherapy eribulin, is an effective treatment for people with TNBC and metabolic d...

55 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT07006506

A Study of Belumosudil in People at Risk of Developing Graft-Versus-Host Disease After a Stem Cell Transplant

The purpose of this study is to find out whether adding belumosudil to a usual approach for reducing the risk of graft-versus-host disease (GVHD) may be an effective GVHD prevention approach for peopl...

46 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05675930

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

The purpose of this study is to find out whether photobiomodulation/PBM therapy using the Thor LX2.3 therapy system is a safe and effective treatment for oral Graft-Versus-Host Disease/GVHD....

44 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06110793

A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer

The purpose of this study is to test whether the combination of lenvatinib, pembrolizumab, and fulvestrant is a safe and effective treatment that causes few or mild side effects in people with ER+/HER...

43 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05534438

A Study on Adding Precisely Targeted Radiation Therapy (Stereotactic Body Radiation Therapy) to the Usual Treatment Approach (Drug Therapy) in People With Breast Cancer

The purpose of this study is to see if using Stereotactic Body Radiation Therapy/SBRT to treat a single metastatic site where cancer has worsened may be an effective treatment for people with oligomet...

40 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06411821

Ulixertinib in People With Histiocytic Neoplasms

The researchers are doing this study is to find out whether ulixertinib is an effective and safe treatment for people with histiocytic neoplasms....

38 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06251973

A Study of agenT-797 in Combination With Botensilimab, Balstilimab, Ramucirumab, and Paclitaxel for People With Esophageal, Gastric, or Gastro-esophageal Junction Cancer

Participants will receive study treatment with agenT-797, botensilimab, balstilimab, ramucirumab, and paclitaxel. When participants start each agent will depend on how their disease is affecting them....

37 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT04683679

A Study of Radiation Therapy With Pembrolizumab and Olaparib or Other Radiosensitizers in Women Who Have Triple-Negative or Hormone-Receptor Positive/Her2 Negative Breast Cancer

The purpose of this study is to find out whether adding pembrolizumab, with or without olaparib, to standard radiation therapy is a safe and effective treatment for metastatic breast cancer, , and to ...

34 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06130280

A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer

The researchers are doing this study to see if one session of high-dose contrast-enhanced MRI-guided SBRT (stereotactic body radiation therapy) is effective for colorectal cancer that has spread to th...

32 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT04092673

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

This clinical trial is a Phase 1-2, open-label, sequential-group, dose-escalation and cohort-expansion study evaluating the safety, pharmacokinetics (PK), pharmacodynamics, and antitumor activity of Z...

30 participants
Effector Therapeutics
View Study Details
RecruitingHarrison, NYNCT05010031

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

This study will test whether reduced-dose radiotherapy is an effective treatment for metastatic tumors with an ATM mutation. The researchers want to find the lowest dose of radiation that would still ...

29 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT06873815

A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD)

The researchers are doing this study to see if giving people fluorescein sodium as an IV infusion before their vulvectomy for treating extramammary Paget's disease (EMPD) can help surgeons with perfor...

27 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05873205

Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation

The purpose of this study is to find out whether isatuximab is an effective treatment for people who developed immune cytopenias/ICs after allogeneic hematopoietic cell transplant/allo-HCT....

25 participants
Memorial Sloan Kettering Cancer Center
View Study Details
RecruitingHarrison, NYNCT05736419

A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

Hematopoietic Cell Transplantation/HCT involves receiving healthy blood-forming cells (stem cells) from a donor to replace the diseased or damaged cells in participants' bone marrow. The researchers t...

24 participants
Memorial Sloan Kettering Cancer Center
View Study Details

About Ankylosing Spondylitis Clinical Trials in Harrison

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 24 ankylosing spondylitis clinical trials recruiting participants in Harrison, NY. These studies are seeking a combined 2,252 participants. Research is being sponsored by Memorial Sloan Kettering Cancer Center, Effector Therapeutics. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Harrison — FAQ

Are there ankylosing spondylitis clinical trials in Harrison?

Yes, there are 24 ankylosing spondylitis clinical trials currently recruiting in Harrison, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Harrison?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Harrison research site will contact you about next steps.

Are clinical trials in Harrison free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Harrison studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 24 active trials in Harrison are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated March 2, 2026 from ClinicalTrials.gov